Trial Profile
Levosimendan vs furosemide in patients with advanced chronic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2012
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Furosemide
- Indications Chronic heart failure; Left ventricular dysfunction
- Focus Therapeutic Use
- 03 Oct 2012 New trial record
- 28 Aug 2012 Results published in the Journal of Cardiovascular Pharmacology.